Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study
Chabriat, Hugues, Bassetti, Claudio L, Marx, Ute, Picarel-Blanchot, Françoise, Sors, Aurore, Gruget, Celine, Saba, Barbara, Wattez, Marine, Audoli, Marie-Laure, Hermann, Dirk M
Published in Current controlled trials in cardiovascular medicine (03.02.2020)
Published in Current controlled trials in cardiovascular medicine (03.02.2020)
Get full text
Journal Article
Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale
Montejo, Angel L, Deakin, J F W, Gaillard, Raphael, Harmer, Catherine, Meyniel, Florent, Jabourian, Artin, Gabriel, Cecilia, Gruget, Celine, Klinge, Corinna, MacFayden, Christine, Milligan, Holly, Mullings, Emma, Goodwin, Guy
Published in Journal of psychopharmacology (Oxford) (01.10.2015)
Published in Journal of psychopharmacology (Oxford) (01.10.2015)
Get more information
Journal Article
Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study
Stein, Dan J, Ahokas, Antti, Jarema, Marek, Avedisova, Alla S, Vavrusova, Livia, Chaban, Oleg, Gruget, Céline, Olivier, Valérie, Picarel-Blanchot, Françoise, de Bodinat, Christian
Published in European neuropsychopharmacology (01.05.2017)
Published in European neuropsychopharmacology (01.05.2017)
Get full text
Journal Article